
zzso of solid tumors remains a challenge despite the tremendous success of zzso zzso zzso zzso and zzso zzso zzso in treating zzso zzso For a variety of reasons, clinical trials of zzso zzso against solid tumors have not led to responses equivalent to those seen against zzso In contrast, promising responses have been observed with zzso zzso that target solid tumor receptors associated with cellular signaling zzso These observations suggest that zzso efficacy of the carrier zzso might be critical to achieving clinical zzso Here, we review and compare tumor zzso targeted by zzso zzso and zzso zzso used in zzso The review shows that the trend for zzso zzso under zzso development is to also target zzso associated with signaling pathways that are essential for the growth and survival of the zzso 

